0001708138-20-000101.txt : 20200827
0001708138-20-000101.hdr.sgml : 20200827
20200827162132
ACCESSION NUMBER: 0001708138-20-000101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200825
FILED AS OF DATE: 20200827
DATE AS OF CHANGE: 20200827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Plew Daniel P
CENTRAL INDEX KEY: 0001411984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201143134
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-08-25
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001411984
Van Plew Daniel P
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP & General Mgr Industrial O
Common Stock
2020-08-25
4
S
0
10256
609.71
D
36854
D
Common Stock
2020-08-25
4
S
0
7981
610.41
D
28873
D
Common Stock
2020-08-25
4
S
0
1980
611.4
D
26893
D
Common Stock
2020-08-25
4
S
0
4044
612.49
D
22849
D
Common Stock
2020-08-25
4
S
0
1560
613.62
D
21289
D
Common Stock
2020-08-25
4
S
0
1288
614.24
D
20001
D
Common Stock
1028
I
By 401(k) Plan
Represents volume-weighted average price of sales of 10,256 shares of Company stock on August 25, 2020 at prices ranging from $609.18 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
Represents volume-weighted average price of sales of 7,981 shares of Company stock on August 25, 2020 at prices ranging from $610.01 to $610.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,980 shares of Company stock on August 25, 2020 at prices ranging from $611.00 to $611.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
Represents volume-weighted average price of sales of 4,044 shares of Company stock on August 25, 2020 at prices ranging from $612.00 to $612.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,560 shares of Company stock on August 25, 2020 at prices ranging from $613.08 to $613.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,288 shares of Company stock on August 25, 2020 at prices ranging from $614.00 to $614.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
/s/**Daniel P. Van Plew
2020-08-26